Medical Nutrition Therapy (MNT) is a science-based treatment approach that involves personalized dietary plans to adjust nutritional intake for the prevention, management, or improvement of specific diseases. Its core lies in designing tailored nutritional formulas or dietary principles based on the patient's physiological state, disease type, and treatment goals. This therapy is often combined with medications, surgeries, and other treatments, suitable for metabolic disorders, gastrointestinal diseases, and long-term management of chronic illnesses.
Unlike general dietary advice, MNT must be prescribed by a registered dietitian or physician based on the patient's weight, biochemical indicators, and medical history. For example, diabetic patients may require carbohydrate exchange methods, while renal disease patients need to restrict protein intake. Treatment goals may include blood glucose control, blood pressure reduction, or improvement of organ metabolic functions.
Medical Nutrition Therapy is mainly divided into three categories: First, Special Medical Purpose Formula Foods (FSMP), such as peptide-based nutritional supplements or low-protein drinks, which directly support organ metabolic deficiencies. Second, dietary pattern adjustments, such as the Mediterranean diet to reduce cardiovascular risk or ketogenic diet to control epilepsy. Third, nutrient supplementation therapies, such as Omega-3 fatty acids to improve inflammatory responses.
The mechanisms vary depending on the treatment goal: in diabetes management, delaying carbohydrate absorption can smooth blood sugar curves; in kidney disease, restricting phosphorus and potassium intake can reduce renal burden. Some formulas include fibers or probiotics to modulate gut microbiota and improve metabolic functions. Efficacy usually requires regular biochemical monitoring (e.g., HbA1c, creatinine clearance) for dynamic adjustment.
This therapy is suitable for various chronic diseases and special medical conditions, including: 1) Diabetes and metabolic syndrome for blood sugar and lipid control; 2) Patients with kidney disease to delay renal function decline through low-protein diets; 3) Cancer patients during chemotherapy to maintain weight and immune function; 4) Hepatic encephalopathy, restricting protein intake to reduce ammonia metabolism burden.
It is also applicable for postoperative recovery, nutritional support after intestinal surgery, and symptom relief in inflammatory bowel disease (IBD). In Taiwan and Hong Kong, MNT has been incorporated into guidelines for managing chronic diseases such as diabetes and kidney disease, with some medical insurance covering specific formula foods.
The method of administration depends on the condition and includes oral, enteral, or parenteral nutrition. For example, diabetic patients need to consume 50-60% of total daily calories from complex carbohydrates in 6-8 meals, with strict control of carbohydrate and fat ratios. Renal patients may limit protein intake to 0.6-0.8 grams per kilogram of body weight daily and follow a low-potassium diet.
The dosage of formula foods should be calculated based on body weight, activity level, and metabolic needs. For instance, patients with chronic wasting diseases may require 15-20 kcal/kg/day. After starting treatment, weight changes and biochemical indicators should be evaluated every 4-6 weeks, and plans adjusted accordingly. Special formulas must be used under medical supervision and not altered independently.
Main advantages include:
Long-term benefits include delaying disease progression, such as in chronic kidney disease patients, where regular adherence can prolong time to dialysis. Compared to surgery or medication, MNT has a low incidence of side effects and relatively manageable costs, making it suitable for long-term chronic disease management.
Potential side effects include:
Emergency risks include: severe malnutrition, electrolyte imbalances (such as hypernatremia or hypokalemia). During use, blood tests for hemoglobin, albumin, and liver and kidney functions should be monitored every 2-4 weeks to detect abnormalities promptly.
Contraindications include:
During use, attention should be paid to: Strictly avoid unauthorized changes to the diet plan, such as renal patients mistakenly using high-potassium fruits that may trigger arrhythmias. Prior to treatment, inform healthcare providers of any food allergies and medication use history.
Common interactions with medications include:
When combined with surgical treatments, note that early postoperative use of enteral nutrition may be necessary, but high-osmolality formulas should be avoided when gastrointestinal blood supply is compromised. Always confirm all medication details with the attending physician before treatment.
Clinical studies show that regular MNT in diabetic patients can reduce HbA1c by an average of 1.2%-1.8%, comparable to medication effects. Patients with stage 3 chronic kidney disease using low-protein diets can slow eGFR decline by up to 30%. A 2019 Cochrane review indicated that postoperative patients using immunonutrition formulas can reduce infection complications by 40%.
In cancer treatment, prophylactic nutritional support can reduce the incidence of cachexia caused by chemotherapy by 25%. Treatment efficacy should be evaluated through 3-6 months of follow-up, including biochemical indicators, body composition analysis, and symptom improvement assessments.
Alternatives include:
The unique value of MNT lies in its minimally invasive nature and safety, especially suitable for patients with multiple chronic diseases. However, for severe malnutrition or acute critical illnesses, it should be combined with parenteral nutrition or surgical interventions.
It is recommended to adjust the timing of eating and medication under the guidance of a physician or dietitian, based on the drug's action time and meal content. For example, some hypoglycemic drugs should be taken before or after meals, avoiding fasting or excessive intake of certain nutrients. Certain foods (like high-fiber diets) may affect drug absorption, so regular follow-up and adjustments are necessary.
What should I do if I experience bloating or diarrhea during treatment?You can try eating small, frequent meals, avoiding high-fat or high-fiber foods, and choosing easily digestible grains or vegetables. If symptoms persist for more than 48 hours or are accompanied by nausea, contact your healthcare team immediately, as adjustments to the nutritional formula or addition of digestive enzymes may be required.
How should I coordinate diet with exercise to prevent hypoglycemia?It is advised to consume easily absorbed carbohydrates (such as low-GI fruits or whole grains) about an hour before exercise, and to hydrate and consume small amounts of energy every 30 minutes during activity. For high-intensity exercise, adjust the diet based on blood glucose monitoring to avoid overlapping with insulin peak times.
How can I maintain the treatment diet principles during eating out or social gatherings?You can communicate special needs with the restaurant in advance, choose low-salt, low-fat options, and bring healthy snacks (like nuts or unsweetened yogurt) to supplement nutrition. Use the
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
